Clinical Trial: Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Randomized Control Trial on Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia

Brief Summary: To compare the efficacy and cost-effectiveness between purified CD34+ cells and peripheral blood mononuclear cells in treatment of critical limb ischemia

Detailed Summary:
Sponsor: Shanghai Zhongshan Hospital

Current Primary Outcome: major-amputation-free survival rate [ Time Frame: at 6 months ]

Original Primary Outcome: Same as current

Current Secondary Outcome: improvement on transcutaneous partial oxygen pressure [ Time Frame: at 3 months ]

Original Secondary Outcome: Same as current

Information By: Shanghai Zhongshan Hospital

Dates:
Date Received: March 14, 2014
Date Started: March 2014
Date Completion: December 2018
Last Updated: April 16, 2016
Last Verified: April 2016